Vanguard Group Inc 10x Genomics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,933,549 shares of TXG stock, worth $119 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,933,549

Previous 10,972,930 0.36%

Holding current value

$119 Million

Previous $248 Million 36.63%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$13.18 - $21.31 $519,041 - $839,209	-39,381 Reduced 0.36%	10,933,549 $157 Million
Q3 2024 Nov 13, 2024	BUY	$15.71 - $23.49 $12.3 Million - $18.4 Million	783,673 Added 7.69%	10,972,930 $248 Million
Q2 2024 Aug 13, 2024	BUY	$19.45 - $37.37 $21.2 Million - $40.6 Million	1,087,721 Added 11.95%	10,189,257 $198 Million
Q1 2024 May 10, 2024	BUY	$36.08 - $54.3 $3.25 Million - $4.9 Million	90,204 Added 1.0%	9,101,536 $342 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $3.7 Million - $6.2 Million	107,815 Added 1.21%	9,011,332 $504 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $14.5 Million - $22.4 Million	354,921 Added 4.15%	8,903,517 $367 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $12 Million - $13.8 Million	-235,025 Reduced 2.68%	8,548,596 $477 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $12.8 Million - $20.3 Million	363,610 Added 4.32%	8,783,621 $490 Million
Q4 2022 Feb 10, 2023	BUY	$24.4 - $41.3 $3.55 Million - $6.02 Million	145,652 Added 1.76%	8,420,011 $307 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $12.7 Million - $23.5 Million	446,601 Added 5.71%	8,274,359 $236 Million
Q2 2022 Aug 12, 2022	BUY	$36.95 - $82.41 $3.52 Million - $7.85 Million	95,235 Added 1.23%	7,827,758 $354 Million
Q1 2022 May 13, 2022	BUY	$55.7 - $145.79 $9.94 Million - $26 Million	178,481 Added 2.36%	7,732,523 $588 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $6.75 Million - $9.13 Million	-50,002 Reduced 0.66%	7,554,042 $1.13 Billion
Q3 2021 Nov 12, 2021	BUY	$145.58 - $192.14 $76.4 Million - $101 Million	524,475 Added 7.41%	7,604,044 $1.11 Billion
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $950 Million - $1.43 Billion	7,079,569 New	7,079,569 $1.39 Billion

Others Institutions Holding TXG

# of Institutions

302

Shares Held

96.5M

Call Options Held

76.4K

Put Options Held

132K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.04B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc 10x Genomics, Inc. Transaction History